8E70 logo

Pharmasimple MUN:8E70 Stock Report

Last Price

€0.04

Market Cap

€27.8k

7D

0%

1Y

-100.0%

Updated

26 Jun, 2023

Data

Company Financials

8E70 Stock Overview

Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. More details

8E70 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Pharmasimple SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Pharmasimple
Historical stock prices
Current Share Price€0.04
52 Week High€700.00
52 Week Low€0.04
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Change-100.00%
3 Year Changen/a
5 Year Changen/a
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

8E70DE Specialty RetailDE Market
7D0%-1.7%-0.4%
1Y-100.0%36.9%7.9%

Return vs Industry: 8E70 underperformed the German Specialty Retail industry which returned -19.5% over the past year.

Return vs Market: 8E70 underperformed the German Market which returned 6.3% over the past year.

Price Volatility

Is 8E70's price volatile compared to industry and market?
8E70 volatility
8E70 Average Weekly Movementn/a
Specialty Retail Industry Average Movement5.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8E70 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 8E70's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aMichael Willemswww.pharmasimple.com

Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. It offers face products comprising accessories, creams, cleansers, scrubs, masks, supplements, tanners, and other care products; body and hair, makeup, solar, and products; waters and perfumes; food supplements; health accessories, bandages, devices, first-aid, and pain/ache, as well as diet products; and masks, thermometers, glover, air purifiers, and home and hand hygiene products. The company also provides toilet, and mom and baby care; sliming and sports products; daily, oral, and organic hygiene products; and aromatherapy, bach flowers, homeopathy, apitherapy, herbalism, phytotherapy, gemmotherapy, floral elixirs, balneotherapy, light therapy, lithotherapy, and magnetotherapy medicines; as well as male, animals, and organic and natural products.

Pharmasimple SA Fundamentals Summary

How do Pharmasimple's earnings and revenue compare to its market cap?
8E70 fundamental statistics
Market cap€27.76k
Earnings (TTM)-€4.79m
Revenue (TTM)€31.93m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8E70 income statement (TTM)
Revenue€31.93m
Cost of Revenue€34.35m
Gross Profit-€2.42m
Other Expenses€2.37m
Earnings-€4.79m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 8E70 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/26 08:07
End of Day Share Price 2023/03/29 00:00
Earnings2021/06/30
Annual Earnings2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmasimple SA is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Florent Thy-TineTPICAP Midcap